Our website is currently under development. A simplified version is shown here. Please visit again soon.

Biomarker for ALS disease progression identified

The absence of suitable biomarkers for amyotrophic lateral sclerosis (ALS) poses a major obstacle to therapy development. For this reason, the discovery and validation of potential disease progression and pharmacodynamic biomarkers has been one of the top priorities...